Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03770312
PHASE4

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study

Sponsor: Yonsei University

View on ClinicalTrials.gov

Summary

One of the most effective drug in the primary prevention of cardiovascular disease is statins. The protective effects of statin on developement of cardiovascular disease has been demonstrated in elderly individuals. Since side effects of statin are more common in elderly individuals than in younger individuals, clinical guidelines recommend that use of low intensity statin is considered in elderly individuals. However, there are few randomized clinical trials evaluating the safety and efficacy of different intensity statins in elderly individuals. This is a multicenter, prospective, randomized clinical trial to compare efficacy and safety between low and high intensity statin for primary prevention of cardiovacsular disease in elderly individuals.

Key Details

Gender

All

Age Range

70 Years - Any

Study Type

INTERVENTIONAL

Enrollment

724

Start Date

2020-03-05

Completion Date

2026-01-16

Last Updated

2025-11-18

Healthy Volunteers

Yes

Interventions

DRUG

Low intensity statin

Use of low intensity statin for primary prevention of cardiovascular disease.

DRUG

Moderate intensity statin

Use of moderate intensity statin for primary prevention of cardiovascular disease.

Locations (1)

Division of Cardiology, Cardiovascular Center, Severance Hospital, Yonsei University College of Medicine

Seoul, South Korea